Cargando…
Nivolumab treatment followed by atezolizumab induced encephalitis and neuropathy with antiganglioside antibodies
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649576/ https://www.ncbi.nlm.nih.gov/pubmed/34926841 http://dx.doi.org/10.1016/j.ensci.2021.100386 |
| _version_ | 1784611027428573184 |
|---|---|
| author | Watanabe, Shohei Yoshizumi, Kazuki Moriguchi, Sayaka Higashiyama, Tomoki Negi, Yoshiki Mikami, Koji Kimura, Takashi |
| author_facet | Watanabe, Shohei Yoshizumi, Kazuki Moriguchi, Sayaka Higashiyama, Tomoki Negi, Yoshiki Mikami, Koji Kimura, Takashi |
| author_sort | Watanabe, Shohei |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8649576 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-86495762021-12-17 Nivolumab treatment followed by atezolizumab induced encephalitis and neuropathy with antiganglioside antibodies Watanabe, Shohei Yoshizumi, Kazuki Moriguchi, Sayaka Higashiyama, Tomoki Negi, Yoshiki Mikami, Koji Kimura, Takashi eNeurologicalSci Letter to the Editor Elsevier 2021-12-03 /pmc/articles/PMC8649576/ /pubmed/34926841 http://dx.doi.org/10.1016/j.ensci.2021.100386 Text en © 2021 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Letter to the Editor Watanabe, Shohei Yoshizumi, Kazuki Moriguchi, Sayaka Higashiyama, Tomoki Negi, Yoshiki Mikami, Koji Kimura, Takashi Nivolumab treatment followed by atezolizumab induced encephalitis and neuropathy with antiganglioside antibodies |
| title | Nivolumab treatment followed by atezolizumab induced encephalitis and neuropathy with antiganglioside antibodies |
| title_full | Nivolumab treatment followed by atezolizumab induced encephalitis and neuropathy with antiganglioside antibodies |
| title_fullStr | Nivolumab treatment followed by atezolizumab induced encephalitis and neuropathy with antiganglioside antibodies |
| title_full_unstemmed | Nivolumab treatment followed by atezolizumab induced encephalitis and neuropathy with antiganglioside antibodies |
| title_short | Nivolumab treatment followed by atezolizumab induced encephalitis and neuropathy with antiganglioside antibodies |
| title_sort | nivolumab treatment followed by atezolizumab induced encephalitis and neuropathy with antiganglioside antibodies |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649576/ https://www.ncbi.nlm.nih.gov/pubmed/34926841 http://dx.doi.org/10.1016/j.ensci.2021.100386 |
| work_keys_str_mv | AT watanabeshohei nivolumabtreatmentfollowedbyatezolizumabinducedencephalitisandneuropathywithantigangliosideantibodies AT yoshizumikazuki nivolumabtreatmentfollowedbyatezolizumabinducedencephalitisandneuropathywithantigangliosideantibodies AT moriguchisayaka nivolumabtreatmentfollowedbyatezolizumabinducedencephalitisandneuropathywithantigangliosideantibodies AT higashiyamatomoki nivolumabtreatmentfollowedbyatezolizumabinducedencephalitisandneuropathywithantigangliosideantibodies AT negiyoshiki nivolumabtreatmentfollowedbyatezolizumabinducedencephalitisandneuropathywithantigangliosideantibodies AT mikamikoji nivolumabtreatmentfollowedbyatezolizumabinducedencephalitisandneuropathywithantigangliosideantibodies AT kimuratakashi nivolumabtreatmentfollowedbyatezolizumabinducedencephalitisandneuropathywithantigangliosideantibodies |